Fundz

Paige Secures Additional Investment from Goldman Sachs Towards Series B Funding Round

PRIVATEApr 23, 2020

Round Type

Series B

New YorkHealthcareSoftware

Description

Paige, the leader in computational pathology which is transforming the diagnosis and treatment of cancer, today announced it has received additional funding from Goldman Sachs Merchant Banking Division, which will be added to the recently announced Series B financing round. Paige will use this new capital to further develop the company’s diagnostic and test products for the biopharma industry, while strengthening its leadership position in clinical AI for pathologists and development of the Paige platform for remote viewing and routine clinical practice. Additionally, Paige has added David Castelblanco, Managing Director at Goldman Sachs, to its Board of Directors. David brings with him a wealth of experience as an investor and board member working with leading cancer treatment centers internationally.

Quick answer

Paige raised an undisclosed amount in a Series B round, dated April 23, 2020. Paige is based in New York, New York, United States.

How much did Paige raise?
Paige raised an undisclosed amount in a Series B round on April 23, 2020.
What does Paige do?
Paige is using the power of AI to drive a new era of cancer discovery and treatment.
Where is Paige based and how big is it?
Paige is based in New York, New York, United States. Fundz records about 40 employees.
Who are the decision-makers at Paige?
Fundz holds 2 contacts at Paige. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Software around the same time

Companies in the same sectors as Paige that raised within 45 days of this round, from Fundz verified event records.

  • Zipari, Inc. raised $10M on May 27, 2020.
  • Q/C Technologies, Inc. raised $482K (Seed) on May 21, 2020.
  • Ankyra Therapeutics raised $14M on May 15, 2020.
  • Streamex Corp. raised $600K on May 5, 2020.
  • Medable Inc. raised $25M (Funding Round) on May 4, 2020.
  • Medable Inc. raised $26M on April 28, 2020.

Who to call at Paige, and when

A new round usually means Paige is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Paige raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Paige, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Paige. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Paige

Location

11 TIMES SQUARE

New York, New York, United States

About

Paige is using the power of AI to drive a new era of cancer discovery and treatment. To improve the lives of patients with cancer, Paige has created a cloud-based platform that transforms pathologists’ workflow and increases diagnostic confidence as well as productivity, all on a global scale. Paige is the first company to receive FDA approval for a clinical AI application in digital pathology. The same Paige technology empowers pharmaceutical companies to more effectively evaluate treatment options for patients and design new biomarkers for drug development so that every patient gets precise treatment options.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Paige raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contacts30 people are listed at Paige. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Paige's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Paige raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.